Researcher.Life Logo

ChemMedChem : Impact Factor & More

eISSN: 1860-7187pISSN: 1860-7179

Aims and Scope of ChemMedChem

ChemMedChem is a biweekly peer-reviewed scientific journal covering medicinal chemistry. It is published by Wiley-VCH on behalf of Chemistry Europe. In addition to original research in the form of full papers and shorter communications, the journal contains review-type articles (reviews, minireviews, patent reviews, essays, highlights) as well as occasional book reviews and conference reports. Less

Key Metrics

CiteScore
5.6
Impact Factor
< 5
SJR
Q2Biochemistry
SNIP
0.89
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on ChemMedChem

ChemMedChem Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher WILEY-V C H VERLAG GMBH
Language English
Frequency Semi-monthly
General Details
LanguageEnglish
FrequencySemi-monthly
Publication Start Year2006
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in ChemMedChem ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in ChemMedChem

Identification of 2-Substituted-3-Hydroxy-2,3-Dihydroquinazolin-4(1H) Ones as Cell-Active Inhibitors of KDM4A Lysine Demethylase.
  • 27 May 2026
  • ChemMedChem
A 24-Day MicroCycle Journey to Interleukin-17 Inhibitors: From Library Design to Central Core Prioritization and Capping Group Identification.
  • 27 May 2026
  • ChemMedChem
Design, Synthesis, and Evaluation of Coumarin-Rasagiline Hybrids as Multifunctional Neuroprotective Agents.
  • 27 May 2026
  • ChemMedChem
Triple-Negative Breast Cancer Versus Non-Triple-Negative Breast Cancer: The Impact of Pd and Pt Complexes on Basal-Like Triple-Negative Breast Cancer.
  • 14 May 2026
  • ChemMedChem
Discovery and Evaluation of 6,7-Dimethoxy-1,2,3,4-Tetrahydroisoquinoline Derivatives as P-gp Inhibitors to Overcome Multidrug Resistance in Eca109/VCR Cells.
  • 14 May 2026
  • ChemMedChem
Design, Synthesis, and Biological Evaluation of Small-Molecule PD-1/PD-L1 Inhibitors Bearing a Rigid Benz[d]oxazole Skeleton.
  • 14 May 2026
  • ChemMedChem
Identification of 2-Substituted-3-Hydroxy-2,3-Dihydroquinazolin-4(1H) Ones as Cell-Active Inhibitors of KDM4A Lysine Demethylase.
  • 27 May 2026
  • ChemMedChem
A 24-Day MicroCycle Journey to Interleukin-17 Inhibitors: From Library Design to Central Core Prioritization and Capping Group Identification.
  • 27 May 2026
  • ChemMedChem
Design, Synthesis, and Evaluation of Coumarin-Rasagiline Hybrids as Multifunctional Neuroprotective Agents.
  • 27 May 2026
  • ChemMedChem
Triple-Negative Breast Cancer Versus Non-Triple-Negative Breast Cancer: The Impact of Pd and Pt Complexes on Basal-Like Triple-Negative Breast Cancer.
  • 14 May 2026
  • ChemMedChem
Discovery and Evaluation of 6,7-Dimethoxy-1,2,3,4-Tetrahydroisoquinoline Derivatives as P-gp Inhibitors to Overcome Multidrug Resistance in Eca109/VCR Cells.
  • 14 May 2026
  • ChemMedChem
Design, Synthesis, and Biological Evaluation of Small-Molecule PD-1/PD-L1 Inhibitors Bearing a Rigid Benz[d]oxazole Skeleton.
  • 14 May 2026
  • ChemMedChem

FAQs on ChemMedChem